ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP — Insider transactions at Revance Therapeutics, Inc. / ATS MEDICAL INC | InsiderLens

FrançaisSign in Try free 14d

ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP

USReporting entity

Transactions

55

Issuers

3

Buys / Sells

3/0

Last tx

03 Feb 2015

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Revance Therapeutics, Inc.	8,000	reported	08 Apr 2014	tx 25+4,142,962−4,134,962
ENTELLUS MEDICAL INC	0	reported	03 Feb 2015	tx 12+3,813,196−13,841,028
ATS MEDICAL INC	0	reported	12 Aug 2010	tx 18+1,100,000−12,163,831

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	98,302	—
03 Feb 2015	PURCHASE	ENTELLUS MEDICAL INC	23,061	17.00 USD
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	226,095	—
03 Feb 2015	PURCHASE	ENTELLUS MEDICAL INC	319,853	17.00 USD
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	3,135,858	—
03 Feb 2015	PURCHASE	ENTELLUS MEDICAL INC	10,027	17.00 USD
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	8,325,325	—	deriv
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	600,259	—	deriv
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	132,228	—	deriv
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	4,218,108	—	deriv
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	304,126	—	deriv
03 Feb 2015	CONVERSION	ENTELLUS MEDICAL INC	260,982	—	deriv
08 Apr 2014	OTHER	Revance Therapeutics, Inc.	8,000	0.00 USD	deriv
11 Feb 2014	CONVERSION	Revance Therapeutics, Inc.	200,538	—
11 Feb 2014	CONVERSION	Revance Therapeutics, Inc.	2,781,396	—
11 Feb 2014	CONVERSION	Revance Therapeutics, Inc.	596,812	—
11 Feb 2014	EXERCISE	Revance Therapeutics, Inc.	369,124	—
11 Feb 2014	EXERCISE	Revance Therapeutics, Inc.	11,560	—
11 Feb 2014	CONVERSION	Revance Therapeutics, Inc.	43,029	—
11 Feb 2014	EXERCISE	Revance Therapeutics, Inc.	26,605	—
11 Feb 2014	CONVERSION	Revance Therapeutics, Inc.	87,190	—
11 Feb 2014	CONVERSION	Revance Therapeutics, Inc.	18,708	—
11 Feb 2014	EXERCISE	Revance Therapeutics, Inc.	11,560	—	deriv
11 Feb 2014	CONVERSION	Revance Therapeutics, Inc.	18,708	—	deriv
11 Feb 2014	CONVERSION	Revance Therapeutics, Inc.	12,668	—	deriv